These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3833264)

  • 1. Effects of tenoxicam, a new anti-inflammatory drug, on in vitro neutrophil activation.
    Laghi Pasini F; Capecchi PL; Ceccatelli L; Orrico A; Pasqui AL; Di Perri T
    Boll Chim Farm; 1985 Nov; 124(11):477-82. PubMed ID: 3833264
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro effects of non-steroidal anti-inflammatory drugs on production of oxygen radicals evaluated by the chemiluminescent response of polymorphonuclear leukocytes].
    Mazzullo G; Calabria AA; Lalumera M; Fioravanti A; Bacarelli MR; Pucci G; Renieri A
    Boll Soc Ital Biol Sper; 1985 Aug; 61(8):1193-8. PubMed ID: 4063109
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of piroxicam on neutrophil and monocyte-macrophage function.
    Scheinberg MA; Rueda HO; Matheus PC
    Eur J Rheumatol Inflamm; 1983; 6(1):36-40. PubMed ID: 6861812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tenoxicam on inflammation and immune cellular function.
    Scheinberg MA; Santoro J; Sanchez ML
    Braz J Med Biol Res; 1990; 23(11):1143-8. PubMed ID: 2133022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piroxicam enhances phagocytosis of Escherichia coli by human polymorphonuclear neutrophils.
    Lingaas E; Midtvedt T
    Biochem Biophys Res Commun; 1982 Nov; 109(1):14-20. PubMed ID: 6760862
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological and biochemical activities of tenoxicam (Ro 12-0068), a new non-steroidal anti-inflammatory drug.
    Bradshaw D; Cashin CH; Kennedy AJ; Roberts NA
    Agents Actions; 1984 Dec; 15(5-6):569-77. PubMed ID: 6099694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic studies on Ro 12-0068, a new non-steroidal anti-inflammatory drug (author's transl)].
    Tanaka Y; Maeda M; Nakamura K
    Nihon Yakurigaku Zasshi; 1981 May; 77(5):531-52. PubMed ID: 7297961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of leukocyte peroxidases in the metabolism of tenoxicam.
    Ichihara S; Tomisawa H; Fukazawa H; Tateishi M
    Biochem Pharmacol; 1985 Apr; 34(8):1337-8. PubMed ID: 2986643
    [No Abstract]   [Full Text] [Related]  

  • 9. An in vivo and in vitro investigation of the phototoxic potential of tenoxicam, a new non-steroidal anti-inflammatory agent.
    Anderson R; Eftychis HA; Weiner A; Findlay GH
    Dermatologica; 1987; 175(5):229-34. PubMed ID: 3678549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What piroxicam does and why.
    Huskisson EC
    Eur J Rheumatol Inflamm; 1983; 6(1):1-2. PubMed ID: 6407840
    [No Abstract]   [Full Text] [Related]  

  • 11. Second piroxicam symposium.
    Eur J Rheumatol Inflamm; 1983; 6(1):1-138. PubMed ID: 6861808
    [No Abstract]   [Full Text] [Related]  

  • 12. The neutrophil in rheumatoid arthritis: its role and the inhibition of its activation by nonsteroidal antiinflammatory drugs.
    Abramson S; Edelson H; Kaplan H; Given W; Weissmann G
    Semin Arthritis Rheum; 1983 Aug; 13(1 Suppl 1):148-53. PubMed ID: 6312608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of tenoxicam in rats.
    Ichihara S; Tsuyuki Y; Tomisawa H; Fukazawa H; Nakayama N; Tateishi M; Joly R
    Xenobiotica; 1984 Sep; 14(9):727-39. PubMed ID: 6516446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of piroxicam on the chemotaxis and random migration of polymorphonuclear leucocytes after induction of immune and non immune inflammations.
    Pham-Huy D; Roch-Arveiller M; Lenoir M; Muntaner O; Giroud JP
    Biomed Pharmacother; 1985; 39(7):381-5. PubMed ID: 2937463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase 1 clinical evaluation of piroxicam].
    Ryumachi; 1980 Jun; 20(3):214-9. PubMed ID: 7414433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biliary excretion of tenoxicam in cholecystectomized patients].
    Tamimura H; Mukaihara S; Mine Y; Yotsumoto F; Setoyama M; Suzuki T; Kuruma I
    Nihon Geka Hokan; 1984 Nov; 53(6):779-85. PubMed ID: 6534309
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of isoxicam and piroxicam on renal function in healthy subjects.
    Darragh AS
    Br J Clin Pract; 1985 Apr; 39(4):144-7. PubMed ID: 3940157
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of tenoxicam for the treatment of rheumatoid arthritis].
    Torisu T; Nobenaga T; Kwasaki Y
    Ryumachi; 1984 Aug; 24(4):295-308. PubMed ID: 6393367
    [No Abstract]   [Full Text] [Related]  

  • 19. [Scientific basis of piroxicam (Felden). Pharmacological properties and mechanism of action].
    Wiseman EH
    Wien Med Wochenschr; 1980; 130 Spec No():27-31. PubMed ID: 7456463
    [No Abstract]   [Full Text] [Related]  

  • 20. Tenoxicam in soft-tissue rheumatism.
    Schorn D
    S Afr Med J; 1986 Mar; 69(5):301-3. PubMed ID: 3515589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.